First report of <i>Nocardia wallacei</i> infection in an immunocompetent patient in Zhejiang province-Reference-Cited by-同舟云学术

First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province

Published:2024-01-01 Issue:1 Volume:19 Page:
ISSN:2391-5412
Container-title:Open Life Sciences
language:en
Short-container-title:

Author:

Pan Wei¹,Zhuo Bingqian²³,Wang Sumei³,Long Jieping³,Xu Wei⁴,Chen Mengyuan⁵,Hong Xin⁶,Ge Yumei³⁴⁶

Affiliation:

1. Department of Clinical Laboratory, Haiyan People’s Hospital , Haiyan , Zhejiang, 314300 , China

2. School of Public Health, Hangzhou Medical College , Hangzhou , 310053 , China

3. Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College , Hangzhou , Zhejiang, 310014 , China

4. School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University , Hangzhou , Zhejiang, 310053 , China

5. The Second Clinical Medical College, Zhejiang Chinese Medical University , Hangzhou , Zhejiang, 310053 , China

6. Department of Green Pharmaceutical Collaborative Innovation Center, School of Pharmacy, Zhejiang University of Technology , Hangzhou , Zhejiang, 310014 , China

Abstract

Abstract Nocardiosis is an infectious disease caused by Nocardia spp., mainly affecting immunocompromised hosts. Nocardia infection is not common; especially Nocardia wallacei infection is even rarer. The patient, female, 61 years old, farmer, has been working in the field for a long time and has normal immune function. Her main clinical manifestation was persistent back pain. Chest-enhanced computed tomography showed pulmonary inflammation. Rare pathogen Nocardia wallacei was detected in alveolar lavage fluid using matrix-assisted laser destructive ionization time-of-flight mass spectrometry. She received treatment with linezolid and was discharged after her condition improved.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/biol-2022-0891/pdf

Reference25 articles.

1. Haussaire D, Fournier PE, Djiguiba K, Moal V, Legris T, Purgus R, et al. Nocardiosis in the south of France over a 10-years period, 2004-2014. Int J Infect Dis. 2017;57:13–20.

2. Margalit I, Lebeaux D, Tishler O, Goldberg E, Bishara J, Yahav D, et al. How do I manage nocardiosis? Clin Microbiol Infect. 2021;27(4):550–8.

3. King AS, Castro JG, Dow GC. Nocardia farcinica lung abscess presenting in the context of advanced HIV infection: Spontaneous resolution in response to highly active antiretroviral therapy alone. Can J Infect Dis Med Microbiol. 2009;20(3):e103–6.

4. Brown-Elliott BA, Brown JM, Conville PS, Wallace Jr RJ. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259–82.

5. Traxler RM, Bell ME, Lasker B, Headd B, Shieh WJ, McQuiston JR. Updated review on nocardia species: 2006-2021. Clin Microbiol Rev. 2022;35(4):e0002721.